Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
PETS's Cash to Debt is ranked higher than
99% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.34 vs. PETS: No Debt )
Ranked among companies with meaningful Cash to Debt only.
PETS' s 10-Year Cash to Debt Range
Min: 0.11   Max: No Debt
Current: No Debt

Equity to Asset 0.91
PETS's Equity to Asset is ranked higher than
99% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.34 vs. PETS: 0.91 )
Ranked among companies with meaningful Equity to Asset only.
PETS' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.93
Current: 0.91

0.17
0.93
Interest Coverage No Debt
PETS's Interest Coverage is ranked higher than
98% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.55 vs. PETS: No Debt )
Ranked among companies with meaningful Interest Coverage only.
PETS' s 10-Year Interest Coverage Range
Min: 15.27   Max: 9999.99
Current: No Debt

15.27
9999.99
F-Score: 5
Z-Score: 32.89
M-Score: -3.42
WACC vs ROIC
13.52%
66.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 12.04
PETS's Operating margin (%) is ranked higher than
93% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.68 vs. PETS: 12.04 )
Ranked among companies with meaningful Operating margin (%) only.
PETS' s 10-Year Operating margin (%) Range
Min: -26.37   Max: 17.02
Current: 12.04

-26.37
17.02
Net-margin (%) 7.61
PETS's Net-margin (%) is ranked higher than
92% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.88 vs. PETS: 7.61 )
Ranked among companies with meaningful Net-margin (%) only.
PETS' s 10-Year Net-margin (%) Range
Min: -28.25   Max: 10.91
Current: 7.61

-28.25
10.91
ROE (%) 24.03
PETS's ROE (%) is ranked higher than
92% of the 428 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.04 vs. PETS: 24.03 )
Ranked among companies with meaningful ROE (%) only.
PETS' s 10-Year ROE (%) Range
Min: -236.77   Max: 90.8
Current: 24.03

-236.77
90.8
ROA (%) 21.47
PETS's ROA (%) is ranked higher than
98% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.04 vs. PETS: 21.47 )
Ranked among companies with meaningful ROA (%) only.
PETS' s 10-Year ROA (%) Range
Min: -52.2   Max: 47.63
Current: 21.47

-52.2
47.63
ROC (Joel Greenblatt) (%) 113.07
PETS's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 9.18 vs. PETS: 113.07 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PETS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -165.66   Max: 194.27
Current: 113.07

-165.66
194.27
Revenue Growth (3Y)(%) -0.30
PETS's Revenue Growth (3Y)(%) is ranked higher than
51% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.50 vs. PETS: -0.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PETS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.3   Max: 57.8
Current: -0.3

-0.3
57.8
EBITDA Growth (3Y)(%) 2.00
PETS's EBITDA Growth (3Y)(%) is ranked higher than
67% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -11.90 vs. PETS: 2.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PETS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.7   Max: 109.3
Current: 2

-8.7
109.3
EPS Growth (3Y)(%) 2.80
PETS's EPS Growth (3Y)(%) is ranked higher than
71% of the 428 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -70.40 vs. PETS: 2.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PETS' s 10-Year EPS Growth (3Y)(%) Range
Min: -9   Max: 104.1
Current: 2.8

-9
104.1
» PETS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

PETS Guru Trades in Q2 2014

John Buckingham 132,974 sh (+2.20%)
Chuck Royce 351,500 sh (unchged)
John Burbank Sold Out
John Hussman Sold Out
Paul Tudor Jones Sold Out
Jim Simons 1,695,407 sh (-6.70%)
» More
Q3 2014

PETS Guru Trades in Q3 2014

John Buckingham 136,162 sh (+2.40%)
Chuck Royce 351,500 sh (unchged)
Jim Simons 1,589,215 sh (-6.26%)
» More
Q4 2014

PETS Guru Trades in Q4 2014

John Buckingham 137,816 sh (+1.21%)
Jim Simons 1,600,615 sh (+0.72%)
Chuck Royce 351,500 sh (unchged)
Jim Simons 1,600,615 sh (unchged)
» More
Q1 2015

PETS Guru Trades in Q1 2015

James Barrow 212,477 sh (New)
Jim Simons 1,685,032 sh (+5.27%)
John Buckingham 141,371 sh (+2.58%)
Chuck Royce 351,500 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with PETS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.10
PETS's P/E(ttm) is ranked higher than
67% of the 320 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.80 vs. PETS: 19.10 )
Ranked among companies with meaningful P/E(ttm) only.
PETS' s 10-Year P/E(ttm) Range
Min: 11.25   Max: 40.23
Current: 19.1

11.25
40.23
Forward P/E 17.30
PETS's Forward P/E is ranked higher than
58% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 17.30 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 18.50
PETS's PE(NRI) is ranked higher than
78% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 38.00 vs. PETS: 18.50 )
Ranked among companies with meaningful PE(NRI) only.
PETS' s 10-Year PE(NRI) Range
Min: 11.19   Max: 40.4
Current: 18.5

11.19
40.4
P/B 4.40
PETS's P/B is ranked lower than
80% of the 425 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 4.40 )
Ranked among companies with meaningful P/B only.
PETS' s 10-Year P/B Range
Min: 2.33   Max: 13.62
Current: 4.4

2.33
13.62
P/S 1.46
PETS's P/S is ranked lower than
94% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 1.46 )
Ranked among companies with meaningful P/S only.
PETS' s 10-Year P/S Range
Min: 0.84   Max: 3.51
Current: 1.46

0.84
3.51
PFCF 10.50
PETS's PFCF is ranked higher than
84% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 10.50 )
Ranked among companies with meaningful PFCF only.
PETS' s 10-Year PFCF Range
Min: 7.86   Max: 110.44
Current: 10.5

7.86
110.44
POCF 10.32
PETS's POCF is ranked higher than
67% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.62 vs. PETS: 10.32 )
Ranked among companies with meaningful POCF only.
PETS' s 10-Year POCF Range
Min: 7.64   Max: 90.36
Current: 10.32

7.64
90.36
EV-to-EBIT 10.06
PETS's EV-to-EBIT is ranked higher than
87% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.21 vs. PETS: 10.06 )
Ranked among companies with meaningful EV-to-EBIT only.
PETS' s 10-Year EV-to-EBIT Range
Min: 4.7   Max: 25.7
Current: 10.06

4.7
25.7
Shiller P/E 17.40
PETS's Shiller P/E is ranked higher than
81% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 35.58 vs. PETS: 17.40 )
Ranked among companies with meaningful Shiller P/E only.
PETS' s 10-Year Shiller P/E Range
Min: 9.95   Max: 124.94
Current: 17.4

9.95
124.94
Current Ratio 10.84
PETS's Current Ratio is ranked higher than
99% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.99 vs. PETS: 10.84 )
Ranked among companies with meaningful Current Ratio only.
PETS' s 10-Year Current Ratio Range
Min: 0.33   Max: 12.2
Current: 10.84

0.33
12.2
Quick Ratio 7.46
PETS's Quick Ratio is ranked higher than
98% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.54 vs. PETS: 7.46 )
Ranked among companies with meaningful Quick Ratio only.
PETS' s 10-Year Quick Ratio Range
Min: 0.16   Max: 8.1
Current: 7.46

0.16
8.1
Days Inventory 64.75
PETS's Days Inventory is ranked lower than
59% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 49.87 vs. PETS: 64.75 )
Ranked among companies with meaningful Days Inventory only.
PETS' s 10-Year Days Inventory Range
Min: 28.38   Max: 78.88
Current: 64.75

28.38
78.88
Days Sales Outstanding 3.07
PETS's Days Sales Outstanding is ranked higher than
86% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 34.17 vs. PETS: 3.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
PETS' s 10-Year Days Sales Outstanding Range
Min: 2.31   Max: 6.05
Current: 3.07

2.31
6.05

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 4.15
PETS's Dividend Yield is ranked higher than
83% of the 426 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.03 vs. PETS: 4.15 )
Ranked among companies with meaningful Dividend Yield only.
PETS' s 10-Year Dividend Yield Range
Min: 0.51   Max: 5.85
Current: 4.15

0.51
5.85
Dividend Payout 0.78
PETS's Dividend Payout is ranked lower than
52% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.70 vs. PETS: 0.78 )
Ranked among companies with meaningful Dividend Payout only.
PETS' s 10-Year Dividend Payout Range
Min: 0.26   Max: 0.78
Current: 0.78

0.26
0.78
Dividend growth (3y) 9.00
PETS's Dividend growth (3y) is ranked higher than
84% of the 428 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 9.00 )
Ranked among companies with meaningful Dividend growth (3y) only.
PETS' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 26
Current: 9

0
26
Yield on cost (5-Year) 8.86
PETS's Yield on cost (5-Year) is ranked higher than
94% of the 426 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.85 vs. PETS: 8.86 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PETS' s 10-Year Yield on cost (5-Year) Range
Min: 1.08   Max: 12.34
Current: 8.86

1.08
12.34
Share Buyback Rate 0.90
PETS's Share Buyback Rate is ranked higher than
89% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 0.90 )
Ranked among companies with meaningful Share Buyback Rate only.
PETS' s 10-Year Share Buyback Rate Range
Min: 4.1   Max: -48.2
Current: 0.9

Valuation & Return

vs
industry
vs
history
Price/Net Cash 7.70
PETS's Price/Net Cash is ranked higher than
97% of the 397 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 7.70 )
Ranked among companies with meaningful Price/Net Cash only.
PETS' s 10-Year Price/Net Cash Range
Min: 5.34   Max: 23.38
Current: 7.7

5.34
23.38
Price/Net Current Asset Value 5.80
PETS's Price/Net Current Asset Value is ranked higher than
96% of the 411 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 5.80 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PETS' s 10-Year Price/Net Current Asset Value Range
Min: 3.24   Max: 40
Current: 5.8

3.24
40
Price/Tangible Book 4.50
PETS's Price/Tangible Book is ranked lower than
63% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.30 vs. PETS: 4.50 )
Ranked among companies with meaningful Price/Tangible Book only.
PETS' s 10-Year Price/Tangible Book Range
Min: 1.56   Max: 36.5
Current: 4.5

1.56
36.5
Price/DCF (Projected) 1.20
PETS's Price/DCF (Projected) is ranked higher than
78% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 1.20 )
Ranked among companies with meaningful Price/DCF (Projected) only.
PETS' s 10-Year Price/DCF (Projected) Range
Min: 0.78   Max: 6.04
Current: 1.2

0.78
6.04
Price/Median PS Value 0.90
PETS's Price/Median PS Value is ranked higher than
81% of the 430 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.40 vs. PETS: 0.90 )
Ranked among companies with meaningful Price/Median PS Value only.
PETS' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 2.01
Current: 0.9

0.33
2.01
Price/Graham Number 2.00
PETS's Price/Graham Number is ranked higher than
59% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 2.00 )
Ranked among companies with meaningful Price/Graham Number only.
PETS' s 10-Year Price/Graham Number Range
Min: 1.45   Max: 6.18
Current: 2

1.45
6.18
Earnings Yield (Greenblatt) 9.90
PETS's Earnings Yield (Greenblatt) is ranked higher than
86% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.10 vs. PETS: 9.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
PETS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 21.2
Current: 9.9

3.9
21.2
Forward Rate of Return (Yacktman) 3.80
PETS's Forward Rate of Return (Yacktman) is ranked higher than
68% of the 429 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.00 vs. PETS: 3.80 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
PETS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.7   Max: 65.7
Current: 3.8

0.7
65.7

Analyst Estimate

Mar16
EPS($) 0.96
EPS without NRI($) 0.96

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, GNC, APNHY, JCOUF, PMC » details
Traded in other countries:PQM.Germany,
PetMed Express, Inc. was incorporated in the state of Florida in January 1996. The company is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company offers consumers an alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. Its current product line contains approximately 3000 SKUS. These products include a majority of the well-known brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Interceptor, Program, Revolution, Deramaxx, and Rimadyl. These pet supplies include: food, beds, crates, stairs, strollers, and other popular pet supplies. Its website allows customers to easily browse and purchase all of its products online. Its operations are subject to regulation by the State of Florida and are licensed as a community pharmacy by the Florida Board of Pharmacy.
» More Articles for PETS

Headlines

Articles On GuruFocus.com
10 High-Yielding Small Caps For A Portfolio Return Boost Apr 23 2015 
mfi march 2015 Feb 25 2015 
Bob Olstein Says Forget Amazon, Buy PetSmart, Teradata Jun 13 2014 
PetMed Express Inc. Is Trying Harder to Push Sales Apr 21 2014 
4 Cash Gushing, Undervalued Small Cap Stocks With Zero Debt Apr 08 2014 
4 Biggest Dividend Challengers with Low Debt and Nice Initial Yields Aug 28 2013 
12 Dividend Stocks Sending More Cash to Shareholders Aug 05 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
comment on PETS Mar 02 2013 
comment on PETS Mar 02 2013 

More From Other Websites
PETMED EXPRESS INC Financials May 28 2015
10-K for PetMed Express, Inc. May 24 2015
No Bosses for Zappos, What About its Parent - Amazon? - Analyst Blog May 22 2015
PETMED EXPRESS INC Files SEC form 10-K, Annual Report May 22 2015
3 Online Retail and E-Commerce Stocks to Buy Right Now May 07 2015
PETMED EXPRESS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 06 2015
PetMed Beats Q4 Earnings; Sales Improve on Reorder Growth - Analyst Blog May 05 2015
PETMED EXPRESS, INC. D/B/A 1-800-PETMEDS ANNOUNCES ITS FINANCIAL RESULTS FOR FISCAL 2015 AND ITS... May 04 2015
PetMed beats Street 4Q forecasts May 04 2015
PetMed beats Street 4Q forecasts May 04 2015
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Financial Results for Fiscal 2015 and Its... May 04 2015
Here is what Overstock.com’s President acknowledged on last week’s earnings call May 04 2015
Q4 2014 Petmed Express Inc Earnings Release - 08:00 am ET May 04 2015
PETMED EXPRESS INC Files SEC form 8-K, Other Events Apr 28 2015
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 4, 2015 Apr 27 2015
Hubbell's (HUB.B) Q1 Earnings & Revenues Beat Estimates - Analyst Blog Apr 24 2015
10 High-Yield Small-Cap Dividend Stocks Investors Should Consider Right Now Apr 21 2015
Can Etsy Jibe with Wall Street? - Analyst Blog Apr 16 2015
Amazon Prime Instant Video to Offer Orphan Black for Free - Analyst Blog Apr 16 2015
Alibaba to Merge Tmall Online Pharmacy & Alibaba Health - Analyst Blog Apr 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK